Oxford researchers announced Thursday the discovery of a highly virulent strain of HIV that has been lurking in the Netherlands for decades, but because of the effectiveness of modern treatments, is "no cause for alarm."
Feb 6, 2022
0
169
New research sheds light on the lifespans and location of the cells that are responsible for producing HIV, preventing its eradication. Understanding the cells' dynamics may help scientists develop new ways to reduce their ...
Feb 3, 2022
0
48
As the ongoing coronavirus pandemic has demonstrated, new mutations in viral genetic sequences can have significant impacts on the virus's transmissibility and the damage it causes. For many years, there have been concerns ...
Feb 3, 2022
0
201
Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures. ...
Feb 3, 2022
0
124
Over the past two decades, important progress has been made in implementing services to prevent mother-to-child (vertical) transmission of HIV and to access and uptake of HIV testing for infants and children in countries ...
Feb 2, 2022
0
37
(HealthDay)—For men who have sex with men and transgender women (MSM/TGW) at very high risk for HIV (VHR), the benefits of long-acting injectable cabotegravir (CAB-LA) in terms of life expectancy do not necessarily justify ...
Feb 1, 2022
0
3
A Phase 1 clinical trial conducted by University of Minnesota researchers has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of human immunodeficiency virus (HIV). Results of the trial ...
Feb 1, 2022
0
65
Researchers at the University of Missouri and the University of Minnesota have discovered how HIV evades one of the body's best defenses—and their collaborative work could offer hope for future treatments that stop the ...
Jan 27, 2022
0
60
Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.
Jan 27, 2022
0
61
An international research collaboration has found the cancer immunotherapy treatment, pembrolizumab, can reverse HIV latency, the ability for the virus to 'hide' inside cells of people living with HIV on antiretroviral therapy, ...
Jan 26, 2022
0
128
